Newborn Screening definition

Newborn Screening or "newborn screening tests" means screening infants for the disorders of phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, cystic fibrosis, congenital adrenal hyperplasia, medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD), and after October 1, 2007, upon completion of validation studies and establishment of short-term follow-up services, biotinidase deficiency, amino acid disorders, fatty acid oxidation disorders, and organic acid disorders, and upon completion of laboratory validation studies and establishment of short-term follow-up services, Severe Combined Immunodeficiency (SCID) detectable via the Department's laboratory technology utilized in newborn screening and approved by the Commissioner of Health and critical congenital heart
Sample 1Sample 2
Newborn Screening or "newborn screening tests" means screening infants for the disorders of phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, cystic fibrosis, congenital adrenal hyperplasia, medium- chain acyl coenzyme A dehydrogenase deficiency (MCAD), biotinidase deficiency, amino acid disorders, fatty acid oxidation disorders, organic acid disorders. Severe Combined Immunodeficiency (SCID) spinal muscular atrophy (SMA), x- linked adrenoleukodystrophy (X-ALD), mucopolysaccharidosis type I (MPS I) and pompe disease upon completion of laboratory validation studies, establishment of short-term follow-up services, and approval by the Commissioner of Health.
Sample 1
Newborn Screening or "newborn screening tests" means screening infants for the disorders of phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, cystic fibrosis, congenital adrenal hyperplasia, medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD), biotinidase deficiency, amino acid disorders, fatty acid oxidation disorders, organic acid disorders, and upon completion of laboratory validation studies and establishment of short-term follow-up services, Severe Combined Immunodeficiency (SCID) spinal muscular atrophy (SMA), x-linked adrenoleukodystrophy (X-ALD), mucopolysaccharidoisis type I (MPS I) and pompe disease upon completion of laboratory validation studies, and establishment of short-term follow-up services, detectable via the Department's laboratory technology utilized in newborn screening and approvedal by the Commissioner of Health. and cAlso includes Critical congenital heart disease (CCHD) via pulse oximetry screening conducted by birthing facilities on all newborns born in the state of Oklahoma.
Sample 1

Examples of Newborn Screening in a sentence

  • Includes providing coverage for all testing recommended by the California Newborn Screening Program and for participating in the statewide prenatal testing program, ad- ministered by the State Department of Health Services, known as the Expanded Alpha Feto Protein Program.

  • Storage policies and use of the Danish Newborn Screening Biobank.

  • Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.

  • Specimens shall be collected on the Newborn Screening Form Kit using capillary or venous blood.

  • Information can be obtained by contacting the ADH Newborn Screening program.2. Infant Hearing Screening:The LLM must instruct the mother in available resources to obtain the infant hearing screen.

  • The Newborn Screening Program performs more than 11 million screens annually for more than 40 congenital disorders and exposure to the human immunodeficiency virus (HIV).

  • Includes providing coverage for all testing recommended by the California Newborn Screening Program and for participating in the statewide prenatal testing program, ad- ministered by the State Department of Health Services, known as the Expanded Al- pha Feto Protein Program.

  • Provide the Michigan Newborn Screening Saves Babies brochure and the After Newborn Screening, Your Baby’s Blood Spots BioTrust consent brochure to parents.

  • In determining which conditions are to be added or deleted from the newborn screening panel, the Commissioner may seek the advice and guidance of the Newborn Screening and Genetics Advisory Committee.

  • If hand-delivered, the Newborn Screening form shall be delivered within 48 hours of the time the appropriate specimen was collected.


More Definitions of Newborn Screening

Newborn Screening or "newborn screening tests" means screening infants for the disorders of phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, cystic fibrosis, congenital adrenal hyperplasia, medium-chain acyl conenzyme A dehydrogenase deficiency (MCAD), biottinidase deficiency, amino acid disorders, fatty acid oxidation disorders, organic acid disorders. Severe Combined Immunodeficiency (SCID) spinal muscular atrophy (SMA), x-linked adrenoleukodystrophy (X-ALD), mucopolysaccharidoisis type I (MPS I) and pompe disease upon completion of laboratory validation studies, establishment of short-term follow-up services, and approval by the Commissioner of Health. Also includes critical congenital heart disease (CCHD) via pulse oximetry screening conducted by birthing facilities on all newborns born in the state of Oklahoma.
Sample 1
Newborn Screening or "testing" means the testing of a blood sample for classical phenylketonuria (PKU) and certain other amino acid, organic acid, and fatty acid oxidation disorders, primary hypothyroidism, classical galactosemia, congenital adrenal hyperplasia due to 21-hydroxylase deficiency, biotinidase deficiency, sickle cell disease/trait, cystic fibrosis, and lysosomal storage disorders, and severe combined immunodeficiency. At times, variant forms of some disorders, or related conditions, may also be identified.
Sample 1
Newborn Screening means the DBS testing of infants.
Sample 1
Newborn Screening means the testing of infants to identify those at increased risk for
Sample 1
Newborn Screening or "newborn screening tests" means the use of various laboratory and clinical tests to screening screen infants for the certain inherited disorders where a potential net benefit and availability of effective treatments have been demonstrated. of phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, cystic fibrosis, congenital adrenal hyperplasia, medium-chain acyl coenzyme A dehydrogenase deficiency (MCAD), biotinidase deficiency, amino acid disorders, fatty acid oxidation disorders, organic acid disorders, Severe Combined Immunodeficiency (SCID) spinal muscular atrophy (SMA), x-linked adrenoleukodystrophy (X-ALD), mucopolysaccharidoisis type I (MPS I) and pompe disease upon completion of laboratory validation studies, establishment of short-term follow-up services, and approval by the Commissioner of Health.
Sample 1
Newborn Screening means the process of collecting a few drops of blood from the newborn onto an appropriate collection card and performing biochemical testing for determining if the newborn has a heritable condition.
Sample 1

Related to Newborn Screening

  • Health screening means the use of one or more diagnostic tools to test a person for the presence or precursors of a particular disease.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Healing arts screening means the testing of human beings using x-ray machines for the detection or evaluation of health indications when such tests are not specifically and individually ordered by a licensed practitioner of the healing arts legally authorized to prescribe such x-ray tests for the purpose of diagnosis or treatment.

  • Newborn means a baby less than nine days old.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Prosthesis means an artificial substitute for a missing body part.

  • Antipsychotic medications means that class of drugs

  • HCD means the California Department of Housing and Community Development.

  • Orthotics means the science and practice of evaluating, measuring, designing, fabricating, assembling, fitting, adjusting, or servicing an orthosis under an order from a licensed physician or podiatrist for the correction or alleviation of neuromuscular or musculoskeletal dysfunction, disease, injury, or deformity.

  • Transplant hospital means a hospital that furnishes organ transplants and other medical and surgical specialty services required for the care of transplant patients.

  • Medical cannabis card means the same as that term is defined in Section 26-61a-102.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Routine patient care costs means Covered Medical Expenses which are typically provided absent a clinical trial and not otherwise excluded under the Policy. Routine patient care costs do not include:

  • HIV means human immunodeficiency virus.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Psychotherapy or "Therapy" means a goal directed process using generally accepted clinical approaches provided face-to-face by a qualified service provider with consumers in individual, group or family settings to promote positive emotional or behavioral change.

  • Medical physicist means a person trained in evaluating the performance of mammography equipment and facility quality assurance programs and who meets the qualifications for a medical physicist set forth in 41.6(3)“c.”

  • Psychotropic medication means medication the prescribed intent of which is to affect or alter thought processes, mood, or behavior including but not limited to anti-psychotic, antidepressant, anxiolytic (anti-anxiety), and behavior medications. The classification of a medication depends upon its stated, intended effect when prescribed.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Diagnostic mammography means a method of screening that

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Anesthesiologist means a physician granted clinical privileges to administer anesthesia.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Sadomasochistic abuse means actual or explicitly simulated flagellation or torture by or upon a person who is nude or clad in undergarments, a mask or bizarre costume, or the condition of being fettered, bound or otherwise physically restrained on the part of one so clothed.

  • Patients means both Public Patients and the Private Patients (referred by private doctors/private hospitals);

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;